biobank Korea Home Page
About Us    event    SiteMap    Contact
           
    Makerº°         Itemº°         ±¹³»¾÷ü         Patient         ÀÚ·áâ°í    
 
    Apoxis SA
acquired by TopoTarget A/S

 

Symbion Science Park. Fruebjergvej 3. 2100 Kobenhavn o Denmark
+45-39-17-83-92
+45-39-17-94-92
www.topotarget.com
enquiries@topotarget.com

  APO010: human FAS-ligand protein product generated via MegaLigand¢â proprietary protein technology platform in Phase I clinical trials;APO866: inhibits NAD+ production Phase II clinical trials

  Korean Distributor : ???

  Products information :

  • ### ¡æ ###
Last Updated : Sunday, 31-Jan-2010 12:46:11 KST
Copyright(c)1999-2011   biobank dB   All Rights Reserved